Lubarsky D A, Fisher S D, Slaughter T F, Green C L, Lineberger C K, Astles J R, Greenberg C S, Inge W W, Krucoff M W
Department of Anesthesiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA.
J Clin Anesth. 2000 Mar;12(2):136-41. doi: 10.1016/s0952-8180(00)00126-4.
To evaluate the relationship between perioperative ischemia and serial concentrations of D-dimer, which is a sensitive and specific marker of fibrinolytic activity. Myocardial ischemia and infarction are well-recognized complications of peripheral vascular surgery. We hypothesized that patients at increased risk of perioperative myocardial ischemia might be identified preoperatively by abnormal hemostatic indices.
Prospective clinical outcomes study.
A 1,124-bed tertiary care medical center.
42 ASA physical status II, III, and IV patients undergoing peripheral vascular surgery.
Serial D-dimer concentrations were measured preoperatively, and at 24 and 72 hours postoperatively. Continuous 12-lead ST-segment monitoring (Mortara Instrument, Inc., Milwaukee, WI) was performed with the acquisition of a 12-lead ECG every 20 seconds for 72 hours.
D-dimer measurements were performed in duplicate using the Dimer Gold assay (American Diagnostica, Greenwich CT). Ischemic episodes, as defined by continuous 12-lead ST-segment monitoring, occurred in 49% of patients. There were no demographic differences between ischemic and nonischemic groups. Although baseline D-dimer concentrations were not statistically significantly different between groups, patients experiencing perioperative myocardial ischemia generated significantly less D-dimer during the perioperative period (p = 0. 014).
PATIENTS with an impaired fibrinolytic response, as defined by reduced generation of D-dimer, experienced an increased incidence of perioperative myocardial ischemia.
评估围手术期缺血与D - 二聚体系列浓度之间的关系,D - 二聚体是纤溶活性的敏感且特异的标志物。心肌缺血和梗死是外周血管手术中公认的并发症。我们假设围手术期心肌缺血风险增加的患者可能在术前通过异常的止血指标得以识别。
前瞻性临床结局研究。
一家拥有1124张床位的三级医疗中心。
42例美国麻醉医师协会(ASA)身体状况为II、III和IV级的接受外周血管手术的患者。
术前、术后24小时和72小时测量D - 二聚体系列浓度。采用连续12导联ST段监测(Mortara仪器公司,威斯康星州密尔沃基),每20秒采集一次12导联心电图,持续72小时。
使用Dimer Gold检测法(美国诊断公司,康涅狄格州格林威治)对D - 二聚体进行双份测量。根据连续12导联ST段监测定义的缺血发作发生在49%的患者中。缺血组和非缺血组在人口统计学上无差异。尽管两组间基线D - 二聚体浓度无统计学显著差异,但围手术期发生心肌缺血的患者在围手术期产生的D - 二聚体明显较少(p = 0.014)。
根据D - 二聚体生成减少定义的纤溶反应受损的患者,围手术期心肌缺血的发生率增加。